Semaglutide
AMAZE 7
Novo Nordisk · Phase 3 · Recruiting · Enrollment 650
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Zenagamtide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Semaglutide dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Semaglutide dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |